Verastem (VSTM) Other Accumulated Expenses (2011 - 2026)

Verastem (VSTM) recorded quarterly Other Accumulated Expenses of $3.1 million in Q1 2026, up 4.15% quarter-over-quarter from $3.0 million in Q4 2025, and up 653.0% on a YoY basis from $417000.0 in Q1 2025.

Verastem (VSTM) Other Accumulated Expenses (2011 - 2026) Analysis & Trends

Verastem's Other Accumulated Expenses history runs 16 years deep, the most recent figure standing at $3.1 million for Q1 2026.

  • In Q1 2026, Other Accumulated Expenses rose 653.0% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $3.1 million (up 653.0% YoY), while the FY2025 annual figure was $3.0 million, up 121.85% from the prior year.
  • Other Accumulated Expenses was $3.1 million for Q1 2026 at Verastem, up from $3.0 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $12.6 million in Q2 2022 to a low of $183000.0 in Q2 2025.
  • Historically, Other Accumulated Expenses has averaged $2.4 million across 5 years, with a median of $1.0 million in 2023.
  • The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses jumped 1087.11% in 2022, then plunged 91.85% in 2023.
  • A 5-year view of Other Accumulated Expenses shows it stood at $996000.0 in 2022, then grew by 4.72% to $1.0 million in 2023, then surged by 30.3% to $1.4 million in 2024, then surged by 121.85% to $3.0 million in 2025, then advanced by 4.15% to $3.1 million in 2026.
  • The last three Other Accumulated Expenses figures came in at $3.1 million (Q1 2026), $3.0 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Verastem 407.42 Mn 225.74 Mn 15.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.14 Mn
Dec 31, 2025 3.02 Mn
Sep 30, 2025 2.02 Mn
Jun 30, 2025 183,000.00
Mar 31, 2025 417,000.00
Dec 31, 2024 1.36 Mn
Sep 30, 2024 1.42 Mn
Jun 30, 2024 1.18 Mn
Mar 31, 2024 688,000.00
Dec 31, 2023 1.04 Mn
Sep 30, 2023 9.05 Mn
Jun 30, 2023 1.03 Mn
Mar 31, 2023 943,000.00
Dec 31, 2022 996,000.00
Sep 30, 2022 921,000.00
Jun 30, 2022 12.62 Mn
Mar 31, 2022 914,000.00
Dec 31, 2021 899,000.00
Sep 30, 2021 999,000.00
Jun 30, 2021 1.06 Mn